|Mr. Michael J. Farrell BE, SM, MBA||CEO & Director||2M||2.07M||45|
|Mr. Robert A. Douglas||Pres & COO||1.54M||1.48M||57|
|Mr. Brett A. Sandercock||Chief Financial Officer||756.84k||N/A||50|
|Mr. David B. Pendarvis||Chief Admin. Officer & Global Gen. Counsel||940.42k||1.75M||58|
|Mr. James Hollingshead||Pres of Sleep Bus.||884.13k||N/A||54|
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; and data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
ResMed Inc.’s ISS Governance QualityScore as of September 1, 2017 is 7. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 7; Compensation: 8.